MORGAN STANLEY - INTEC PHARMA LTD JERUSALEM ownership

INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 8 filers reported holding INTEC PHARMA LTD JERUSALEM in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of INTEC PHARMA LTD JERUSALEM
ValueSharesWeighting
Q3 2020$4,000
+33.3%
14,733
+34.5%
0.00%
Q2 2020$3,000
-66.7%
10,952
-75.3%
0.00%
Q1 2020$9,000
+125.0%
44,263
+478.0%
0.00%
Q4 2019$4,000
-66.7%
7,658
-53.0%
0.00%
Q3 2019$12,000
-96.6%
16,285
-80.1%
0.00%
Q2 2019$356,000
-18.0%
81,931
+38.4%
0.00%
Q1 2019$434,000
+81.6%
59,216
+87.1%
0.00%
Q4 2018$239,000
+13.8%
31,648
-14.9%
0.00%
Q3 2018$210,000
+32.9%
37,183
+3.9%
0.00%
Q2 2018$158,000
-16.4%
35,780
+16.2%
0.00%
Q1 2018$189,000
+4625.0%
30,786
+7596.5%
0.00%
Q3 2017$4,000400
+2005.3%
0.00%
Q1 2016$0190.0%0.00%
Q4 2015$0190.00%
Other shareholders

There were no reported owners of INTEC PHARMA LTD JERUSALEM in Q4 2015.

NameSharesValueWeighting ↓
View complete list of INTEC PHARMA LTD JERUSALEM shareholders